Yes, NIPT (noninvasive prenatal testing) screens for Turner syndrome, also known as monosomy X. The test analyzes fragments of fetal DNA circulating in your blood and can flag when only one X chromosome is present instead of the expected two sex chromosomes. However, NIPT is significantly less accurate for Turner syndrome than it is for conditions like Down syndrome, and a positive result requires confirmatory testing before any diagnosis is made.
How NIPT Detects Turner Syndrome
During pregnancy, small fragments of DNA from the placenta enter your bloodstream. NIPT collects a blood sample and analyzes these fragments to estimate whether the expected number of chromosomes are present. For Turner syndrome, the test looks for the absence of a second sex chromosome, meaning the fetus has a single X chromosome rather than the typical XX or XY pair.
NIPT is typically performed at 10 weeks of gestation or later, because earlier in pregnancy the amount of fetal DNA in your blood is too low to produce reliable results. Some newer systems have shown the ability to identify fetal sex as early as 6 to 9 weeks, though standard clinical practice still begins at 10 weeks. Most NIPT panels include sex chromosome conditions alongside trisomies 13, 18, and 21, so Turner syndrome screening is generally part of the standard test rather than something you need to request separately.
Accuracy Is Lower Than for Other Conditions
This is where Turner syndrome screening gets complicated. NIPT performs well for common trisomies like Down syndrome, where positive predictive values often exceed 90%. For monosomy X, the picture is very different. One prenatal diagnosis laboratory analysis found a positive predictive value (PPV) of just 20% for monosomy X. That means out of every five people who received a positive NIPT result for Turner syndrome, only one was carrying a fetus that actually had the condition. The other four were false positives.
That 80% false positive rate is not a flaw in the test’s design so much as a reflection of the biology involved. Several things can cause NIPT to incorrectly flag Turner syndrome, and understanding them helps explain why a positive result should never be treated as a diagnosis.
Why False Positives Are So Common
A positive NIPT result for monosomy X can come from three different sources: the fetus, the placenta, or you.
- Confined placental mosaicism. The placenta may have cells missing an X chromosome while the fetus itself has a completely normal chromosome set. Since NIPT actually reads placental DNA (not fetal DNA directly), this mismatch can trigger a false positive.
- Maternal mosaicism. Most of the cell-free DNA in your blood is your own. If you carry a low-level mosaic form of Turner syndrome, possibly without ever knowing it, that can skew the results. Maternal X chromosome abnormalities account for 9% to 24% of discordant NIPT results for sex chromosome conditions. One large study found that about 1 in 1,305 NIPT screenings flagged a maternal X chromosome abnormality, and Turner syndrome was the most commonly suspected maternal finding, making up nearly 55% of those cases.
- Vanishing twin. If a twin pregnancy was present early on but one embryo stopped developing, residual DNA from that embryo can linger in your bloodstream and affect results.
Because the DNA NIPT analyzes is primarily maternal in origin, conditions affecting the mother’s own X chromosomes have an outsized influence on accuracy for sex chromosome screening specifically.
Mosaicism Makes Detection Harder
Turner syndrome doesn’t always mean every cell in the body is missing an X chromosome. Many cases are mosaic, meaning some cells have the typical two sex chromosomes while others have only one. This is a significant challenge for NIPT, which works by analyzing statistical patterns across millions of DNA fragments. When only a fraction of cells carry the abnormality, the signal becomes weaker and harder to distinguish from background noise.
Research published in the Journal of Medicine and Life concluded directly that NIPT cannot confirm mosaicism. The study documented cases where NIPT flagged a possible risk for monosomy X, but only invasive testing revealed the specific mosaic pattern involved. The authors noted that while NIPT works well for trisomies 13, 18, and 21, it is “not as effective” for sex chromosome conditions. Karyotype analysis of amniotic fluid cells remains the gold standard for detecting sex chromosome abnormalities, including mosaic Turner syndrome.
What Happens After a Positive Result
If your NIPT comes back positive for monosomy X, the next step is confirmatory diagnostic testing. Two options are available, depending on how far along you are.
Chorionic villus sampling (CVS) can be performed between 11 and 14 weeks of pregnancy. It involves taking a small tissue sample from the placenta, which is then sent to a genetics lab for chromosome analysis. Because CVS samples the placenta rather than the fetus directly, it can sometimes reflect placental mosaicism rather than the fetus’s true chromosome makeup.
Amniocentesis is typically done after 14 weeks. A sample of amniotic fluid is drawn from the uterus. The baby sheds cells into this fluid, so the chromosomes analyzed come from the fetus itself. This makes amniocentesis particularly valuable for confirming or ruling out Turner syndrome and for identifying mosaic patterns that NIPT cannot detect.
Both procedures carry a small risk of complications, which is one reason NIPT exists as a screening step in the first place. The goal is to identify which pregnancies warrant the more definitive (but slightly riskier) diagnostic test. Given the high false positive rate for monosomy X on NIPT, many pregnancies flagged will turn out to be unaffected after confirmatory testing.
What a Negative Result Means
A negative NIPT result for monosomy X is generally reassuring, but it does not guarantee Turner syndrome is absent. The test can miss cases, particularly mosaic forms where only a portion of cells are affected. If later ultrasound findings raise concern, such as a thickened nuchal fold, heart defects, or kidney abnormalities, your provider may still recommend diagnostic testing regardless of the earlier NIPT result. NIPT is a screening tool, not a diagnostic one, and that distinction matters most for sex chromosome conditions where its accuracy is lowest.